Skye Bioscience Inc (SKYE) Wheel Strategy

Running a SKYE wheel strategy lets you generate consistent premium income on Skye Bioscience Inc while setting your own entry and exit prices on the underlying. Skye Bioscience Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own SKYE, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best SKYE wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on SKYE, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable SKYE wheel from a losing one.

Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc.

was founded in 2012 and is headquartered in San Diego, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the SKYE wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your SKYE wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.